Home Featured Page 210

Featured

Latest

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

Silo Pharma Reports Third Quarter Results and Operating Highlights

Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’...

Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials

Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

MYND Executes LOI to Enter into a Clinical Research Collaboration with...

COMPASS Pathways plc announces financial results and business highlights for the...

Mindset Pharma Announces Poster Presentation of Preclinical Data for Benchmarking Next-Generation...

PTSF84 – A Brief Check-in From Wonderland

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to...

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

Silo Pharma Reports Third Quarter Results and Operating Highlights

Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’...

Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials

Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

MYND Executes LOI to Enter into a Clinical Research Collaboration with...

COMPASS Pathways plc announces financial results and business highlights for the...

Mindset Pharma Announces Poster Presentation of Preclinical Data for Benchmarking Next-Generation...

PTSF84 – A Brief Check-in From Wonderland

PT272 – Veterans Day 2021

EDITOR PICKS

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to...

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY